Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for displaying human arginase1 on surfaces of escherichia coli

An arginase and Escherichia coli technology, applied in the surface field of human arginase-1, can solve the problems of carrying various viruses, long application time, complicated preparation process, etc. The effect of reducing synthesis cost and simplifying purification steps

Inactive Publication Date: 2016-08-24
HUBEI UNIV
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Arginase is difficult to achieve high-efficiency soluble expression in Escherichia coli, and it is isolated and extracted from the liver, which is the main source of arginase, but there is a risk of carrying various viruses
Human arginase-1 has been secreted and expressed in Pichia pastoris, and the purified human arginase-1 can effectively transform L-Arg into L-Orn after chitin entrapment However, this method has the disadvantages of long time use, complicated preparation process, and easy loss of enzyme activity during operation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for displaying human arginase1 on surfaces of escherichia coli
  • Method for displaying human arginase1 on surfaces of escherichia coli
  • Method for displaying human arginase1 on surfaces of escherichia coli

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] The method of the present invention is used to display human arginase-1 in Escherichia coli. First, the constructed recombinant plasmid pET23a / H 6ARG1-Ag43 transformed Escherichia coli competent cell Rosetta Blue strain, and cultured overnight at 37°C. Then, pick a single colony and inoculate it in 100mL LB medium. The final concentration of antibiotic ampicillin is 100μg / mL. Shake culture at 37°C. The OD value is between 0.5 and 0.6. Incubate for 8 hours. Then, the cells were collected by centrifugation at 12000 RPM at 4°C, washed with pre-cooled PBS for 3 times, and finally resuspended in 10 mL of pre-cooled PBS buffer for later use. Then it was measured by Chinard reaction and converted to the corresponding human arginase-1 enzyme activity. ( picture 3C , picture 4 )

Embodiment 2

[0030] The method of the present invention is used to display human arginase-1 in Escherichia coli. First, the constructed recombinant plasmid pET23a / H 6 D. 6 - ARG1-Ag43 was transformed into Escherichia coli competent cell Rosetta Blue strain, and cultured overnight at 37°C. Then, pick a single colony and inoculate it in 100mL LB medium, the final concentration of antibiotic ampicillin is 100μg / mL, shake culture at 37°C, the OD value is between 0.5 and 0.6, add IPTG, the final concentration is 1mM, 37°C Induction culture was carried out for 8 hours. Then, the cells were collected by centrifugation at 12000 RPM at 4°C, washed with pre-cooled PBS for 3 times, and finally resuspended in 10 mL of pre-cooled PBS buffer for later use. Then it was measured by Chinard reaction and converted to the corresponding human arginase-1 enzyme activity. ( picture 3B , picture 4 )

Embodiment 3

[0032] The method of the present invention is used to display human arginase-1 in Escherichia coli. First, the constructed recombinant plasmid pET23a / H 6 K 6 - ARG1-Ag43 was transformed into Escherichia coli competent cell Rosetta Blue strain, and cultured overnight at 37°C. Then, pick a single colony and inoculate it in 100mL LB medium. The final concentration of antibiotic ampicillin is 100μg / mL. Shake culture at 37°C. The OD value is between 0.5 and 0.6. Incubate for 8 hours. Then, the cells were collected by centrifugation at 12000 RPM at 4°C, washed with pre-cooled PBS for 3 times, and finally resuspended in 10 mL of pre-cooled PBS buffer for later use. Then it was measured by Chinard reaction and converted to the corresponding human arginase-1 enzyme activity. ( picture 3D , picture 4 )

[0033] Various example result analysis

[0034] After flow cytometry analysis, the charged polypeptide 6×Glu and 6×Lys can improve the display efficiency of Antigen 43 protein...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for displaying human arginase1 on surfaces of escherichia coli. The method comprises steps as follows: 1) recombinant plasmids for surface display of human arginase1 are constructed; 2) the recombinant plasmids are converted into escherichia coli competent cells, and genetic engineering strains are obtained; 3) the recombinant strains are subjected to shake-flask culture, and the display efficiency and enzyme activity of human arginase1 are detected; 4) L-Arginine (L-arginine, L-Arg) is efficiently converted by means of the recombinant strains for synthesis of L-Ornithine (L-ornithine, L-Orn). Human arginase1 is effectively displayed on surfaces of escherichia coli cells through improved Type V self-transport protein (Antigen 43), and industrial application of human arginase1 is realized more rapidly. By comparison with an original Type V self-transport protein (Antigen 43) display system, the display efficiency and the enzyme activity of human arginase1 are remarkably improved; by comparison with an existing chitin immobilization method, the synthesis cost is reduced, the technological process is shortened, and the purification procedures are simplified.

Description

technical field [0001] The present invention relates to the surface technology of human arginase-1 (Human Arginase 1), especially through the optimized autotransporter Antigen 43 surface display method, which is a new idea of ​​human arginase I display, New ways, new methods. Background technique [0002] Human arginase-1 exists in human liver cells, participates in the urea metabolic cycle, and catalyzes the hydrolysis of L-Arg to generate L-Orn and urea. Arginase I deficiency can cause a series of related diseases, such as developmental delay, mental retardation, epilepsy and movement disorders. Human arginase-1 is also a potential clinical drug, which can be used to treat cancer. [0003] Arginase is difficult to achieve high-efficiency soluble expression in Escherichia coli, and it is isolated and extracted from the liver, which is the main source of arginase, but there is a risk of carrying various viruses. Human arginase-1 has been secreted and expressed in Pichia p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/78C12N15/70C12N1/21C12R1/19
CPCC12N9/78C12Y305/03001
Inventor 张贞马立新卞璐唐荣兴
Owner HUBEI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com